CrossrefInfokarte
Deep and ultra-deep PSA responses as prognostic biomarkers in metastatic hormone-sensitive prostate cancer. A systematic review and implications for treatment personalization
Cancer Treatment Reviews · 2026-12 · 151 · 103236
DOI: 10.1016/j.ctrv.2026.103236 ↗Abstract
Kein Abstract verfügbar.
EUVIMED